Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis

MLA

Gugliotta, G., et al. Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..06648307a904f4d1e929f198cbb1e417&authtype=sso&custid=ns315887.

APA

Gugliotta, G., Castagnetti, F., Breccia, M., D’Adda, M., Stagno, F., Levato, L., Carella, A., Martino, B., Tiribelli, M., Fava, C., Gozzini, A., Salvucci, M., Cedrone, M., Trabacchi, E., Usala, E., Scortechini, A., Luciano, L., Soverini, S., Cavo, M., … Rosti, G. (2017). Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis.

Chicago

Gugliotta, G, F Castagnetti, M Breccia, M D’Adda, F Stagno, L Levato, Am Carella, et al. 2017. “Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..06648307a904f4d1e929f198cbb1e417&authtype=sso&custid=ns315887.